Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
James P. Collard, Mary K. McKenna, Sunil K. Noothi, Sara S. Alhakeem, Jacqueline R. Rivas, Vivek M. Rangnekar, Natarajan Muthusamy & Subbarao Bondada. (2022) Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice. Leukemia & Lymphoma 63:8, pages 1810-1822.
Read now
Read now
Kyle Crassini, Yandong Shen, Stephen Mulligan & O. Giles Best. (2017) Modeling the chronic lymphocytic leukemia microenvironment in vitro. Leukemia & Lymphoma 58:2, pages 266-279.
Read now
Read now
Varsha Gandhi & Kumudha Balakrishnan. (2012) CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?. Leukemia & Lymphoma 53:10, pages 1849-1850.
Read now
Read now
Articles from other publishers (41)
Congying Zhai, Baoliang Liu, Fanggong Kan, Shuhui Zhai & Ronghua Zhang. (2023) MicroRNA‑27a‑3p regulates the proliferation and chemotaxis of pulmonary macrophages in non‑small cell lung carcinoma tissues through CXCL2. Oncology Letters 26:5.
Crossref
Crossref
Morgane Canonne, Fabienne George & Carlos Graux. (2022) Ex vivo culture of malignant primary B cells. Frontiers in Hematology 1.
Crossref
Crossref
Bihui Pan, Yue Li, Zhangdi Xu, Yi Miao, Hua Yin, Yilin Kong, Xinyu Zhang, Jinhua Liang, Yi Xia, Li Wang, Jianyong Li, Jiazhu Wu & Wei Xu. (2022) Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia. Frontiers in Immunology 13.
Crossref
Crossref
Donald J. Bastin, Jennifer Quizi, Michael A. Kennedy, Natasha Kekre & Rebecca C. Auer. (2022) Current challenges in the manufacture of clinical-grade autologous whole cell vaccines for hematological malignancies. Cytotherapy 24:10, pages 979-989.
Crossref
Crossref
Eva Hoferkova, Sona Kadakova & Marek Mraz. (2022) In Vitro and In Vivo Models of CLL–T Cell Interactions: Implications for Drug Testing. Cancers 14:13, pages 3087.
Crossref
Crossref
Alessandro Allegra, Mario Di Gioacchino, Gabriella Cancemi, Marco Casciaro, Claudia Petrarca, Caterina Musolino & Sebastiano Gangemi. (2022) Specialized Intercellular Communications via Tunnelling Nanotubes in Acute and Chronic Leukemia. Cancers 14:3, pages 659.
Crossref
Crossref
Ming Guan Ng, Khuen Yen Ng, Rhun Yian Koh & Soi Moi Chye. (2021) Potential role of melatonin in prevention and treatment of leukaemia. Hormone Molecular Biology and Clinical Investigation 42:4, pages 445-461.
Crossref
Crossref
Salah Aref, Lamiaa Ebrahim, Shaimaa El-Ashwah, Mohamed El Agdar & Mohamed Ayed. (2021) Relevance of plasma bone marrow Activin-A and CXCL-12 concentration levels as a biomarker in acute myeloid leukemia. Cancer Biomarkers 32:3, pages 263-270.
Crossref
Crossref
Marlon Wendell Athaydes Kerr, Fábio Magalhães-Gama, Hiochelson Najibe Santos Ibiapina, Fabíola Silva Alves Hanna, Lilyane Amorim Xabregas, Eliana Brasil Alves, João Paulo Diniz Pimentel, Maria Perpétuo Socorro Sampaio Carvalho, Andréa Monteiro Tarragô, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Allyson Guimarães da Costa & Adriana Malheiro. (2021) Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy. Frontiers in Oncology 11.
Crossref
Crossref
Zhi-Peng Peng, Ze-Zhou Jiang, Hao-Fan Guo, Meng-Meng Zhou, Yu-Fan Huang, Wan-Ru Ning, Jin-Hua Huang, Limin Zheng & Yan Wu. (2020) Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. Journal of Hepatology 73:4, pages 906-917.
Crossref
Crossref
M. Burgess, Y. C. E. Chen, S. Mapp, A. Blumenthal, P. Mollee, D. Gill & N. A. Saunders. (2020) HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients. Oncogene 39:35, pages 5756-5767.
Crossref
Crossref
Yan Yan, Xiaoyan Li & Jie Gao. (2020) Identification of A‐kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia. Journal of Clinical Laboratory Analysis 34:5.
Crossref
Crossref
Marwan Kwok, Ceri Oldreive, Andy C. Rawstron, Anshita GoelGrigorios Papatzikas, Rhiannon E. JonesSamantha Drennan, Angelo AgathanggelouArchana Sharma-OatesPaul EvansEdward SmithSurita DalalJingwen MaoRobert HollowsNaheema GordonMayumi HamadaNicholas J. DaviesHelen Parry, Andrew D. Beggs, Talha MunirPaul MoretonShankara Paneesha, Guy PrattA. Malcolm R. Taylor, Francesco Forconi, Duncan M. Baird, Jean-Baptiste Cazier, Paul Moss, Peter Hillmen & Tatjana Stankovic. (2020) Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL. Blood 135:6, pages 411-428.
Crossref
Crossref
Jun Yang, Hu Liu, Qian Cao & Wei Zhong. (2020)
Characteristics of
CXCL2
expression in coronary atherosclerosis and negative regulation by microRNA-421
. Journal of International Medical Research 48:2, pages 030006051989615.
Crossref
Crossref
Xiaohong Hao, Mianmian Gu, Jie Sun & Lin Cong. (2019) A‐kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C‐X‐C motif) ligand 1/chemokine (C‐X‐C motif) ligand 2 in acute myeloid leukemia. Journal of Clinical Laboratory Analysis 34:2.
Crossref
Crossref
R. M. Gorczynski. 2020. Tumor Microenvironment. Tumor Microenvironment
47
58
.
Jie Xiong, Shengyu Guo, Zhitong Bing, Yanlin Su & Le Guo. (2019) A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis. Frontiers in Genetics 9.
Crossref
Crossref
Muhammad Haseeb, Muhammad Ayaz Anwar & Sangdun Choi. (2018) Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications. Frontiers in Immunology 9.
Crossref
Crossref
Daniel Primo, Lydia Scarfò, Aliki Xochelli, Mattias Mattsson, Pamela Ranghetti, Ana Belén Espinosa, Alicia Robles, Julian Gorrochategui, Joaquín Martínez-López, Javier de la Serna, Marcos González, Alberto Chaparro Gil, Eduardo Anguita, Sandra Iraheta, Veerendra Munugalavadla, Christophe Quéva, Stacey Tannheimer, Richard Rosenquist, Kostas Stamatopoulos, Joan Ballesteros & Paolo Ghia. (2018)
A novel
ex vivo
high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia
. Oncotarget 9:40, pages 26019-26031.
Crossref
Crossref
Fang Zhu, Lindsay McCaw, David E. Spaner & Reginald M. Gorczynski. (2018) Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro. Leukemia Research 66, pages 28-38.
Crossref
Crossref
Y.C.E. Chen, S. Mapp, A. Blumenthal, M.L. Burgess, R. Mazzieri, S.R. Mattarollo, P. Mollee, D. Gill & N.A. Saunders. (2017) The duality of macrophage function in chronic lymphocytic leukaemia. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 176-182.
Crossref
Crossref
M Burgess, S Mapp, R Mazzieri, C Cheung, L Chambers, S R Mattarollo, P Mollee, D Gill & N A Saunders. (2016) Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients. Oncogene 36:17, pages 2366-2376.
Crossref
Crossref
Lauren A Thurgood, Tim K Chataway, Karen M Lower & Bryone J Kuss. (2017) From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia. Journal of Proteomics 155, pages 73-84.
Crossref
Crossref
S Betrian, L Ysebaert, K H Heider, J P Delord, J J Fournié & A Quillet-Mary. (2016) Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment. Blood Cancer Journal 6:11, pages e496-e496.
Crossref
Crossref
Benchang Guo, Lu ZhangNicholas Chiorazzi & Thomas L. Rothstein. (2016) IL-4 rescues surface IgM expression in chronic lymphocytic leukemia. Blood 128:4, pages 553-562.
Crossref
Crossref
Yu Lu, Shan Li, Liping Ma, Yan Li, Xiaolian Zhang, Qiliu Peng, Cuiju Mo, Li Huang, Xue Qin & Yinkun Liu. (2016) Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC. Scientific Reports 6:1.
Crossref
Crossref
Roberta ValsecchiNadia ColtellaDaniela BelloniManfredi PonenteElisa ten HackenCristina ScielzoLydia ScarfòMaria Teresa Sabrina BertilaccioPaola BrambillaElisa LentiFilippo Martinelli BoneschiAndrea BrendolanElisabetta FerreroMarina FerrariniPaolo Ghia, Giovanni TononMaurilio Ponzoni, Federico Caligaris-Cappio & Rosa Bernardi. (2016) HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment. Blood 127:16, pages 1987-1997.
Crossref
Crossref
A C West, B P Martin, D A Andrews, S J Hogg, A Banerjee, G Grigoriadis, R W Johnstone & J Shortt. (2016) The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. Oncogenesis 5:4, pages e216-e216.
Crossref
Crossref
Carsten U. Niemann, Sarah E.M. Herman, Irina Maric, Julio Gomez-Rodriguez, Angelique Biancotto, Betty Y. Chang, Sabrina Martyr, Maryalice Stetler-Stevenson, Constance M. Yuan, Katherine R. Calvo, Raul C. Braylan, Janet Valdez, Yuh Shan Lee, Deanna H. Wong, Jade Jones, Clare Sun, Gerald E. Marti, Mohammed Z.H. Farooqui & Adrian Wiestner. (2016)
Disruption of
in vivo
Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study
. Clinical Cancer Research 22:7, pages 1572-1582.
Crossref
Crossref
Renata Binato, Nathalia Correa de Almeida Oliveira, Barbara Du Rocher & Eliana Abdelhay. (2015) The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process. Cancer Letters 369:1, pages 134-143.
Crossref
Crossref
Roel Polak, Bob de Rooij, Rob Pieters & Monique L. den Boer. (2015) B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. Blood 126:21, pages 2404-2414.
Crossref
Crossref
Meng-Ya Si, Zhi-Cheng Fan, Ya-zhen Li, Xiao-Lan Chang, Qing-Dong Xie & Xiao-Yang Jiao. (2015) The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis. Journal of Neuro-Oncology 122:2, pages 229-244.
Crossref
Crossref
Arseniy E. Yuzhalin & Anton G. Kutikhin. 2015. Interleukins in Cancer Biology. Interleukins in Cancer Biology
17
61
.
Jung Yoon Bae, Eun Kyoung Kim, Dong Hyun Yang, Xianglan Zhang, Young-Jin Park, Doo Young Lee, Chung Min Che & Jin Kim. (2014) Reciprocal Interaction between Carcinoma-Associated Fibroblasts and Squamous Carcinoma Cells through Interleukin-1α Induces Cancer Progression. Neoplasia 16:11, pages 928-938.
Crossref
Crossref
Natalia Ruiz-Lafuente, María-José Alcaraz-García, Silvia Sebastián-Ruiz, Joaquín Gómez-Espuch, Consuelo Funes, José-María Moraleda, María-Carmen García-Garay, Natividad Montes-Barqueros, Alfredo Minguela, María-Rocío Álvarez-López & Antonio Parrado. (2014) The Gene Expression Response of Chronic Lymphocytic Leukemia Cells to IL-4 Is Specific, Depends on ZAP-70 Status and Is Differentially Affected by an NFκB Inhibitor. PLoS ONE 9:10, pages e109533.
Crossref
Crossref
Russell T Burke, Sarah Meadows, Marc M Loriaux, Kevin S. Currie, Scott A. Mitchell, Patricia Maciejewski, Astrid S. Clarke, Julie A. Dipaolo, Brian J. Druker, Brian J. Lannutti & Stephen E. Spurgeon. (2014) A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor. Oncotarget 5:4, pages 908-915.
Crossref
Crossref
Sara Civini, Ping Jin, Jiaqiang Ren, Marianna Sabatino, Luciano Castiello, Jianjian Jin, Huan Wang, Yuanlong Zhao, Francesco Marincola & David Stroncek. (2013) Leukemia cells induce changes in human bone marrow stromal cells. Journal of Translational Medicine 11:1.
Crossref
Crossref
Melinda Burgess, Devinder Gill, Richa Singhania, Catherine Cheung, Lynne Chambers, Brent A. Renyolds, Louise Smith, Peter Mollee, Nicholas Saunders & Nigel AJ McMillan. (2013) CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia. Clinical Cancer Research 19:20, pages 5675-5685.
Crossref
Crossref
Guohua Rong, Hua Kang, Yajun Wang, Tao Hai & Haichen Sun. (2013) Candidate Markers That Associate with Chemotherapy Resistance in Breast Cancer through the Study on Taxotere-Induced Damage to Tumor Microenvironment and Gene Expression Profiling of Carcinoma-Associated Fibroblasts (CAFs). PLoS ONE 8:8, pages e70960.
Crossref
Crossref
Ranjana Mazumdar, Paul Evans, Rachel Culpin, James Bailey & David Allsup. (2013) The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapy. Leukemia Research 37:6, pages 614-618.
Crossref
Crossref
Agata A. Filip, Bogumi?a Cise?Dorota Koczkodaj, Ewa W?sik-Szczepanek, Tomasz Piersiak & Anna Dmoszy?ska. (2013) Circulating microenvironment of CLL: Are nurse-like cells related to tumor-associated macrophages?. Blood Cells, Molecules, and Diseases 50:4, pages 263-270.
Crossref
Crossref